Article 7 Amendment of Schedule 3A to the POM Order

in column 1 insert, at the appropriate place in the alphabetical order of the entries as they appear in that column, the entry set out in column 1 below, and in column 2, insert, against that entry, the corresponding entry in column 2 below—

in the entry for “Beclometasone dipropionate”, in column 2, after “nasal” add “inhalation”;

in the entry for “Budesonide”, in column 2, after “Nasal” add “inhalation”;

omit the entry for “Cyclizine”;

in the entry for “Diazepam”^f2, in column 2, omit “in palliative care”;

in the entry for “Diclofenac sodium”^f3, in column 2, after “oral” omit “or” and after “rectal” add “or ophthalmic”;

in the entry for “Domperidone”, in column 2, omit “in palliative care”;

in the entry for “Domperidone maleate”, in column 2, omit “in palliative care”;

in the entry for “Flucloxacillin sodium”, in column 2, after “oral” add “or parenteral”;

in the entry for “Hydrocortisone sodium succinate”, in column 2, after “lozenges” add “or parenteral”;

in the entry for “Ipratropium bromide”, in column 2, after “nasal” add “inhalation”;

in the entry for “Lorazepam”^f4, in column 2, omit “in palliative care”;

in the entry for “metoclopramide hydrochloride”, in column 2, omit “in palliative care”;

in the entry for “Midazolam”^f5, in column 2, omit “in palliative care”;

in the entry for “Ranitidine hydrochloride”, in column 2, after “Oral” insert “or parenteral”.